For highest risk Covid patients
(non-hospitalised patients)
New treatments for patients at highest risk of severe disease from Covid 19 infection are available for non-hospitalised patients from Thursday 16 December.
The treatments include Neutralising monoclonal antibodies (nMABs) given by injection, or antiviral tablets which are swallowed.
These treatments being given to patients at a dedicated clinic, known as the Covid Medical Delivery Unit.
GP practices cannot prescribe these treatments and they are only licensed for patients with the highest risk with COVID-19.
People who can benefit from these treatments will receive a letter or email telling them in advance, they may be eligible for these treatments if they test PCR positive for Covid-19. They also may be contacted by their specialist consultant.
We are facing high demand at the moment so please only contact the surgery about new treatments for Covid-19, if you have a medical condition that means you are very high risk and have tested positive for Covid-19.
Covid antiviral trials
If you have tested positive for Covid-19 and would like to take part in trials using antiviral treatments the surgery recommends you to self-refer to the PANORAMIC study where the study organisers will assess your eligibility.